Literature DB >> 2663901

Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects.

B A Davis1.   

Abstract

The biogenic monoamines and their metabolites have been isolated, identified and quantified in human body fluids over the past forty years using a wide variety of chromatographic separation and detection techniques. This review summarizes the results of those studies on normal, psychiatric and neurological subjects. Tables of normal values and the methods used to obtain them should prove to be useful as a reference source for benchmark amine and metabolite concentrations and for successful analytical procedures for their chromatographic separation, detection and quantification. Summaries of the often contradictory results of the application of these methods to psychiatric and neurological problems are presented and may assist in the assessment of the validity of the results of experiments in this field. Finally, the individual, environmental and the methodological factors affecting the concentrations of the amines and their metabolites are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663901     DOI: 10.1016/s0021-9673(01)84617-3

Source DB:  PubMed          Journal:  J Chromatogr


  10 in total

Review 1.  The biochemistry of Tourette's syndrome.

Authors:  P R Chokka; G B Baker; R A Bornstein; C M de Groot
Journal:  Metab Brain Dis       Date:  1995-06       Impact factor: 3.584

Review 2.  Trace amines and Tourette's syndrome.

Authors:  G B Baker; R A Bornstein; V K Yeragani
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

3.  Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics.

Authors:  Sarah W Black; Michael D Schwartz; Tsui-Ming Chen; Marius C Hoener; Thomas S Kilduff
Journal:  Biol Psychiatry       Date:  2016-10-18       Impact factor: 13.382

4.  Trace Amine-Associated Receptor 1 Regulates Wakefulness and EEG Spectral Composition.

Authors:  Michael D Schwartz; Sarah W Black; Simon P Fisher; Jeremiah B Palmerston; Stephen R Morairty; Marius C Hoener; Thomas S Kilduff
Journal:  Neuropsychopharmacology       Date:  2016-09-23       Impact factor: 7.853

5.  Analysis of biogenic amines in plasma of hypertensive patients and a control group.

Authors:  R Andrew; S A Best; D G Watson; J M Midgley; J L Reid; I B Squire
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

6.  Niemann-Pick C1 functions in regulating lysosomal amine content.

Authors:  Allyn M Kaufmann; Jeffrey P Krise
Journal:  J Biol Chem       Date:  2008-06-30       Impact factor: 5.157

7.  Catecholamine levels in plasma and CSF in migraine.

Authors:  F Martínez; J Castillo; J Pardo; M Lema; M Noya
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

8.  Correlations of plasma and urinary phenylacetic acid and phenylethylamine concentrations with eating behavior and mood rating scores in brofaromine-treated women with bulimia nervosa.

Authors:  B A Davis; S H Kennedy; J D'Souza; D A Durden; D S Goldbloom; A A Boulton
Journal:  J Psychiatry Neurosci       Date:  1994-07       Impact factor: 6.186

9.  Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.

Authors:  P R Paetsch; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1992-12       Impact factor: 5.046

10.  CSF concentration gradients of monoamine metabolites in patients with hydrocephalus.

Authors:  J Malm; B Kristensen; J Ekstedt; P Wester
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.